Business briefs: GSK and Sanofi, plus state legislative news
June 24, 2013
7:08 pm
GlaxoSmithKline says it is scaling back on acquisitions; Sanofi’s CEO picks a regulatory fight; Maine wants to allow Ex-US meds; and New York State seeks to empower pharmacists.
High deductibles linked to lower Rx fills and cancer screenings
JAMA’s look into the impact of patient centric care shows that a broader scope is needed to understand the financial and health impact of active patients and how doctors perceive what it means to be engaged with patients.
Business briefs: AbbVie, AstraZeneca, Valeant, Merck, Novo Nordisk
May 28, 2013
4:55 pm
AbbVie’s Niaspan pricing gets a hard look; AstraZeneca buys up heart drug and company; Valeant expands eye care portfolio with B&L; Merck halts Parkinson’s study; Novo explores liraglutide weight loss results.
Business Briefs: Docs question Gleevec price, Sanofi pill may delay MS onset
April 25, 2013
5:17 pm
Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.
Business briefs: Roche, Doximity and Bayer
April 23, 2013
5:43 pm
Roche is shuttering a division and eliminating 170 jobs; Doximity has added another client; a cautiously-worded study indicates antidepressants may be linked to autism; and NICE has endorsed a new use for Bayer’s Xarelto.
CDC figures suggest patients are avoiding medications to save money, and show that out-of-pocket costs for US consumers are rising faster than those for consumers in many other countries
Success in emerging markets hinges on broad network
A pair of studies suggests that consumers are hungry for information, and that price determines how patients perceive their risk for life-threatening conditions.